BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Genocea Biosciences Highlights Key Progress in the Development of its First Vaccine Candidate, Targeting HSV-2


5/4/2012 10:17:19 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences announced today the results of two studies that showcase the company’s efforts to develop the first-ever therapeutic vaccine for HSV-2 (herpes simplex virus type 2). In a poster presentation made at Immunology 2012, the 99th Annual Meeting of the American Association of Immunologists, researchers demonstrated the ability of Genocea’s vaccine candidate (GEN-003) to elicit strong and lasting B and T cell immune responses in preclinical studies. A second presentation highlighted novel insights supporting the hypothesis that a vaccine strategy targeting T cells may provide a significant therapeutic benefit to patients.

Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->